Lin BioScience (ROCO:6696) ROE % Adjusted to Book Value : -6.67% (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience ROE % Adjusted to Book Value?

Lin BioScience's ROE % for the quarter that ended in Jun. 2023 was -48.26%. Lin BioScience's PB Ratio for the quarter that ended in Jun. 2023 was 7.23. Lin BioScience's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -6.67%.

Lin BioScience ROE % Adjusted to Book Value Historical Data

The historical data trend for Lin BioScience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience ROE % Adjusted to Book Value Chart

Lin BioScience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.08

-3.76

-2.52

-3.47

-9.73

Lin BioScience Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-1.40	-1.99	-3.17	-6.67	-10.78

Competitive Comparison of Lin BioScience's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Lin BioScience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lin BioScience's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lin BioScience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Lin BioScience's ROE % Adjusted to Book Value falls into.

Lin BioScience ROE % Adjusted to Book Value Calculation

Lin BioScience's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-40.76%	/	4.19
	=	-9.73%

Lin BioScience's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-48.26%	/	7.23
	=	-6.67%

Lin BioScience ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Lin BioScience's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience (ROCO:6696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110

Website

https://www.linbioscience.com

Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines